A comprehensive review of SHP2 and its role in cancer
MD Asmamaw, XJ Shi, LR Zhang, HM Liu - Cellular Oncology, 2022 - Springer
Src homology 2-containing protein tyrosine phosphatase 2 (SHP2) is a non-receptor protein
tyrosine phosphatase ubiquitously expressed mainly in the cytoplasm of several tissues …
tyrosine phosphatase ubiquitously expressed mainly in the cytoplasm of several tissues …
Recent advances of SHP2 inhibitors in cancer therapy: current development and clinical application
X Yuan, H Bu, J Zhou, CY Yang… - Journal of medicinal …, 2020 - ACS Publications
SHP2 (Src homology-2 domain-containing protein tyrosine phosphatase-2) is a non-
receptor protein tyrosine phosphatase that removes tyrosine phosphorylation. Functionally …
receptor protein tyrosine phosphatase that removes tyrosine phosphorylation. Functionally …
Identification of TNO155, an allosteric SHP2 inhibitor for the treatment of cancer
MJ LaMarche, M Acker, A Argintaru… - Journal of medicinal …, 2020 - ACS Publications
SHP2 is a nonreceptor protein tyrosine phosphatase encoded by the PTPN11 gene and is
involved in cell growth and differentiation via the MAPK signaling pathway. SHP2 also plays …
involved in cell growth and differentiation via the MAPK signaling pathway. SHP2 also plays …
Double-edged roles of protein tyrosine phosphatase SHP2 in cancer and its inhibitors in clinical trials
Phosphorylation is a reversible post-translational modification regulated by phosphorylase
and dephosphorylase to mediate important cellular events. Src homology-2-containing …
and dephosphorylase to mediate important cellular events. Src homology-2-containing …
Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment
The nonreceptor protein tyrosine phosphatase SHP2 (encoded by PTPN11) integrates
growth and differentiation signals from receptor tyrosine kinases (RTKs) into the …
growth and differentiation signals from receptor tyrosine kinases (RTKs) into the …
Strategies targeting protein tyrosine phosphatase SHP2 for cancer therapy
Y Song, S Wang, M Zhao, X Yang… - Journal of medicinal …, 2022 - ACS Publications
The protein tyrosine phosphatase SHP2 encoded by PTPN11 is a promising therapeutic
target for cancer therapy, while the multifaceted roles of SHP2 complicate the drug discovery …
target for cancer therapy, while the multifaceted roles of SHP2 complicate the drug discovery …
Discovery of SHP2-D26 as a first, potent, and effective PROTAC degrader of SHP2 protein
M Wang, J Lu, M Wang, CY Yang… - Journal of medicinal …, 2020 - ACS Publications
Src homology 2 domain-containing phosphatase 2 (SHP2) is an attractive therapeutic target
for human cancers and other human diseases. Herein, we report our discovery of potent …
for human cancers and other human diseases. Herein, we report our discovery of potent …
Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition
JR LaRochelle, M Fodor, V Vemulapalli… - Nature …, 2018 - nature.com
Activating mutations in PTPN11, encoding the cytosolic protein tyrosine phosphatase SHP2,
result in developmental disorders and act as oncogenic drivers in patients with hematologic …
result in developmental disorders and act as oncogenic drivers in patients with hematologic …
[HTML][HTML] Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
Src homology containing protein tyrosine phosphatase 2 (SHP2) represents a noteworthy
target for various diseases, serving as a well-known oncogenic phosphatase in cancers. As …
target for various diseases, serving as a well-known oncogenic phosphatase in cancers. As …
Turn and face the strange: § a new view on phosphatases
M Köhn - ACS central science, 2020 - ACS Publications
Phosphorylation as a post-translational modification is critical for cellular homeostasis.
Kinases and phosphatases regulate phosphorylation levels by adding or removing …
Kinases and phosphatases regulate phosphorylation levels by adding or removing …